Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 9/20 | 0.33 |
| ▸ | PPARA | Q07869 | 6/20 | 0.33 |
| ▸ | PPARD | Q03181 | 5/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.33 |
| ▸ | PTGES | O14684 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14235163 | 0.88 | HSD17B3 (0.42) | HSD17B3ALDH1A1PKML3MBTL1GAA | |
| SCHEMBL14234820 | 0.86 | LMNA (0.40) | ALDH1A1PPARGMEN1MAPTRAB9A | |
| SCHEMBL15944267 | 0.82 | LMNA (0.38) | ALDH1A1PPARGMAPTRAB9A | |
| SCHEMBL14234370 | 0.81 | ALDH1A1 (0.41) | HSD17B3ALDH1A1PKML3MBTL1GAA | |
| SCHEMBL15945492 | 0.79 | LMNA (0.40) | ALDH1A1PPARGMAPTRAB9A | |
| SCHEMBL15945527 | 0.79 | ALDH1A1 (0.41) | HSD17B3ALDH1A1PKML3MBTL1MAPT | |
| SCHEMBL14234563 | 0.78 | ALDH1A1 (0.43) | HSD17B3ALDH1A1PKML3MBTL1GAA | |
| SCHEMBL15944441 | 0.78 | NMT1 (0.37) | ALDH1A1PPARGMAOBMEN1NPC1 | |
| SCHEMBL17172430 | 0.77 | PPARA (0.36) | HSD17B3ALDH1A1PKMPPARGPPARA | |
| SCHEMBL15945526 | 0.77 | ALDH1A1 (0.41) | HSD17B3ALDH1A1PKML3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9414588-B2 | Herbicide composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-08-16 | — | — | US | disclosed |
| EP-2713755-B1 | CYCLOHEXANONE COMPOUNDS AND HERBICIDES COMPRISING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2016-02-24 | — | — | EP | disclosed |
| US-20150289505-A1 | HERBICIDE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-15 | — | — | US | disclosed |
| US-9101140-B2 | Cyclohexanone compounds and herbicides comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-08-11 | — | — | US | disclosed |
| US-20140228219-A1 | CYCLOHEXANONE COMPOUNDS AND HERBICIDES COMPRISING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-14 | — | — | US | disclosed |
| WO-2012165648-A1 | CYCLOHEXANONE COMPOUNDS AND HERBICIDES COMPRISING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140228219-A1 | CYCLOHEXANONE COMPOUNDS AND HERBICIDES COMPRISING THE SAME | CBR3, CBR1, CYP2S1 | HSD17B3 537/4885ALDH1A1 1329/4885PKM 2407/4885 |
| US-20150289505-A1 | HERBICIDE COMPOSITION | DDT, DHFR, DERL1 | HSD17B3 556/4885ALDH1A1 215/4885PKM 1010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.